EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Influence of Single Nucleotide Polymorphisms on CRS Outcomes: A Preliminary Observational Study

Antonino Maniaci iD, Paolo Bonacci, Stefania Stefani, Salvatore Cocuzza iD, Federico Merlino, Alberto Maria Saibene iD, Giuseppe Sangiorgio, Juan Maza-Solano iD, Jerome R Lechien iD, Ignazio La Mantia, Nicolo' Musso

The Laryngoscope · 2025

DOI: 10.1002/lary.31719 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Laryngoscope, 2025. Verfasst von Antonino Maniaci und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Surgery, University of Enna "Kore", Enna, Italy. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide, Antibodies, Monoclonal, Humanized, Sinusitis, Rhinitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective(s) To conduct a preliminary investigation into the relationship between specific SNP variants, type II inflammation, and the effectiveness of dupilumab therapy and surgery in patients with CRS.

Methods

In this prospective study, 48 subjects were enrolled, comprising 32 CRS patients and 16 healthy controls. The CRS patients were subjected to either dupilumab therapy or endoscopic surgery according to EPOS guidelines. SNP variants were identified using the TaqMan SNP genotyping technique. The identified SNP profiles were compared between the control group and CRS patients, and their potential influence on treatment outcomes was evaluated. Treatment responses were assessed based on symptom scores, such as SS‐I, SNOT‐22, disease progression using the NPS findings, and SNP profiles at a 6‐month follow‐up. The primary measures included the Nasal Polyp Score, Smell Identification Test (SIT) score, and SNOT‐22 outcomes.

Results

Dupilumab therapy and surgery significantly decreased NPS, with the last showing superior results. However, dupilumab therapy resulted in a significantly improved SIT score. Significant differences were observed in SNP profiles, particularly with rs1800629 (TNFA), rs2856838 (IL1a), rs17561 (IL1a), and rs1805011 (IL4R). In particular, the expression of rs2856838 and rs1805011 variants in the dupilumab group was associated with significantly better SIT and SNOT‐22 outcomes than non‐expressors. Also, the surgery group patients expressing the rs2856838 variant reported significant improvements in SNOT‐22 scores.

Conclusion

These preliminary findings suggest that SNP genotypes may guide personalized treatment strategies for CRS. Further larger prospective studies are required to confirm these initial observations. Level of Evidence 2 Laryngoscope , 135:570–578, 2025

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymorphism, Single NucleotideAntibodies, Monoclonal, HumanizedSinusitisRhinitisHumansMaleFemaleProspective StudiesMiddle AgedAdultTreatment OutcomeEndoscopyCase-Control StudiesGenotype

Stichwörter der Autor:innen

CRSSNPdupilumabgenetic polymorphisms

Substanzen

Antibodies, Monoclonal, Humanizeddupilumab

Autor:innen und Institutionen

  • Faculty of Medicine and Surgery, University of Enna "Kore", Enna, Italy.
  • Research Committee, Rhynology Study Group of the Young-Otolaryngologists of the International Federations of Oto-Rhino-Laryngological Societies (YO-IFOS), Paris, France.
  • Section of Microbiology, Department of Biomedical and Biotechnological Sciences (BIOMETEC), Microbiologia Medica Molecolare e Antibiotico Resistenza (MMARLab), University of Catania, Catania, Italy.
  • Section of Biochemistry, Department of Biomedical and Biotechnological Sciences (BIOMETEC), Microbiologia Medica Molecolare e Antibiotico Resistenza (MMARLab), University of Catania, Catania, Italy.
  • Department of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia" ENT Section, University of Catania, Catania, Italy.
  • Department of Otolaryngology-Head and Neck, San Paolo Hospital, University of Milan, Milan, Italy.

ORCID-Profile: Antonino Maniaci, Salvatore Cocuzza, Alberto Maria Saibene, Juan Maza-Solano, Jerome R Lechien

Zitieren

APA

Maniaci, A., Bonacci, P., Stefani, S., Cocuzza, S., Merlino, F., Saibene, A. M., Sangiorgio, G., Maza-Solano, J., Lechien, J. R., La Mantia, I., & Musso, N. (2025). Influence of Single Nucleotide Polymorphisms on CRS Outcomes: A Preliminary Observational Study. The Laryngoscope. https://doi.org/10.1002/lary.31719

Vancouver

Maniaci A, Bonacci P, Stefani S, Cocuzza S, Merlino F, Saibene AM, et al. Influence of Single Nucleotide Polymorphisms on CRS Outcomes: A Preliminary Observational Study. The Laryngoscope. 2025. doi:10.1002/lary.31719

BibTeX
@article{Maniaci2025,
  author = {Maniaci, Antonino and Bonacci, Paolo and Stefani, Stefania and Cocuzza, Salvatore and Merlino, Federico and Saibene, Alberto Maria and Sangiorgio, Giuseppe and Maza-Solano, Juan and Lechien, Jerome R and La Mantia, Ignazio and Musso, Nicolo'},
  title = {Influence of Single Nucleotide Polymorphisms on CRS Outcomes: A Preliminary Observational Study},
  journal = {The Laryngoscope},
  year = {2025},
  doi = {10.1002/lary.31719}
}
Kostenlos starten →